Skip to main content
. 2020 Jul 17;13(9):1202–1209. doi: 10.1016/j.jiph.2020.07.002

Table 1.

Baseline characteristics of patients infected with COVID-19.

All patient Disease Severity
p value
Non-severe Severe
N 1663 799 864  
Age
 Median (IQR) 64.0(52.0−71.0) 61.0(47.0−69.0) 66.0(57.0−73.0) <0.0001
 Age groups (years), n (%) <0.0001
<30 38(2.3) 26(3.3) 12(1.4)
30−49 311(18.7) 202(25.3) 109(12.6)
50−69 826(49.7) 378(47.3) 448(51.9)
≥70 488(29.3) 193(24.2) 295(34.1)
Women, n (%) 825(49.6) 415(51.9) 410(47.5) 0.07
Occupation, n (%) <0.0001
 Others 896(53.9) 476(59.6) 420(48.6)
 Medical staff 46(2.8) 33(4.1) 13(1.5)
 Retirees 568(34.2) 216(27.0) 352(40.7)
 Farmers / workers 153(9.2) 74(9.3) 79(9.1)
Exposure history, n (%)
 Huanan seafood market exposure 11(0.7) 6(0.8) 5(0.6) 0.67
 Family infection 123(7.4) 58(7.3) 65(7.5) 0.84
Time from onset to diagnosis, Median (IQR), days 9.0(5.0−14.0) 9.0(4.0-14.0) 10.0(5.0-15.0) 0.007
Time from onset to admission, Median (IQR), days 10.0(6.0−14.0) 9.0(6.0−14.0) 10.0(7.0−15.0) 0.01
Length of hospital stay, Median (IQR), days 17.0(13.0−19.0) 18.0(15.0−20.0) 17.0(11.0−18.0) <0.0001
Clinical outcomes at data cutoff, n (%) <0.0001
 Hospitalization 1061(63.8) 519(65.0) 542(62.7)
 Improvement and discharge 433(26.0) 280(35.0) 153(17.7)
 Death 169(10.2) 0(0.0) 169(19.6)
Comorbidity, n (%)
 Hypertension 347(20.9) 142(17.8) 205(23.7) 0.003
 Diabetes 245(14.7) 85(10.6) 160(18.5) <0.0001
 Coronary heart disease 131(7.9) 46(5.8) 85(9.8) 0.002
 Chronic obstructive pulmonary disease 62(3.7) 25(3.1) 37(4.3) 0.21
 Cerebrovascular disease 57(3.4) 24(3.0) 33(3.8) 0.36
 Chronic liver disease 38(2.3) 16(2.0) 22(2.6) 0.46
 Chronic renal disease 31(1.9) 16(2.0) 15(1.7) 0.69
 Cancer 19(1.1) 6(0.8) 13(1.5) 0.15

Data are medians (IQR) or number (%). COVID-19, coronavirus disease 2019; IQR, inter-quartile ranges. The percentages were calculated column-wise.